Effects of endothelin receptor antagonists and nitric oxide on myogenic tone and alpha-adrenergic-dependent contractions of rabbit resistance arteries

Cardiovasc Res. 1999 Aug 15;43(3):755-61. doi: 10.1016/s0008-6363(99)00170-4.

Abstract

Regulation of vascular contractions by endothelium-derived endothelin-1 (ET-1) and nitric oxide (NO) may vary depending on the stimulus.

Objectives: To investigate if ET-1 receptor stimulation and NO contributed to a similar extent to the regulation of pressure- and alpha-adrenergic receptor (AR) agonist-induced smooth muscle contraction.

Methods: Rabbit mesenteric arteries (150-200 microns) were isolated, cannulated and pressurized. Changes in diameter were recorded as a function of the perfusion pressure (PP) or alpha-AR agonist addition at a PP of 60 mmHg. All experiments were performed in the presence of indomethacin (10 mumol 1(-1)).

Results: At a PP of 60 mmHg, myogenic tone (MT) developed to represent 17 +/- 1% of the minimal diameter. The magnitude of the MT was increased by 140% (P < 0.05) by the inhibition of NO production with N omega-nitro-L-arginine (L-NOARG). Bosentan, an ETA/B receptor antagonist, and BQ 123, a selective ETA receptor antagonist, decreased (P < 0.05) MT either alone or in combination with L-NOARG by approximately 30%. Phenylephrine (Phe), an alpha 1-AR agonist, induced contraction; the sensitivity to Phe (pD2, 6.2 +/- 0.2) was unaffected by bosentan or BQ 123 alone but increased (P < 0.05) by L-NOARG (pD2, 7.3 +/- 0.5). Further addition of bosentan or BQ 123 restored the sensitivity to Phe to its control value. Oxymetazoline (OXY), an alpha 2-AR agonist, induced contraction; the sensitivity to OXY (pD = 2, 7.7 +/- 0.2) was unaffected by L-NOARG, bosentan or BQ 123.

Conclusion: Our results indicate that pressure-induced tone is independently regulated by endothelium-derived NO and ET-1. In contrast, alpha 1-AR stimulation-induced tone is sensitive to ET-1 in the absence of NO, whereas occupation of alpha 2-AR mediates a contraction unregulated by the endothelium.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adrenergic alpha-2 Receptor Antagonists
  • Adrenergic alpha-Agonists / pharmacology
  • Animals
  • Bosentan
  • Endothelin Receptor Antagonists*
  • Enzyme Inhibitors / pharmacology*
  • In Vitro Techniques
  • Male
  • Mesenteric Arteries
  • Nitric Oxide Synthase / antagonists & inhibitors*
  • Nitroarginine / pharmacology*
  • Oxymetazoline / pharmacology
  • Peptides, Cyclic / pharmacology
  • Phenylephrine / pharmacology
  • Rabbits
  • Sulfonamides / pharmacology*
  • Vasoconstriction / drug effects*

Substances

  • Adrenergic alpha-2 Receptor Antagonists
  • Adrenergic alpha-Agonists
  • Endothelin Receptor Antagonists
  • Enzyme Inhibitors
  • Peptides, Cyclic
  • Sulfonamides
  • Phenylephrine
  • Nitroarginine
  • Oxymetazoline
  • Nitric Oxide Synthase
  • Bosentan
  • cyclo(Trp-Asp-Pro-Val-Leu)